To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Leucine-rich repeat kinas… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.

Journal article
Authors Andrea Carmine Belin
Marie Westerlund
Olof Sydow
Karin Lundströmer
Anna Håkansson
Hans Nissbrandt
Lars Olson
Dagmar Galter
Published in Movement disorders : official journal of the Movement Disorder Society
Volume 21
Issue 10
Pages 1731-4
ISSN 0885-3185
Publication year 2006
Published at Institute of Neuroscience and Physiology, Department of Pharmacology
Pages 1731-4
Language en
Keywords Adult, Aged, Aged, 80 and over, Case-Control Studies, Cohort Studies, Female, Genetics, Population, Heterozygote Detection, Humans, Male, Middle Aged, Mutation, genetics, Parkinson Disease, diagnosis, genetics, Penetrance, Protein-Serine-Threonine Kinases, genetics, Reference Values, Sweden, Variation (Genetics), genetics
Subject categories Molecular neurobiology, Neurology


Specific variants of Leucine-rich repeat kinase 2 (LRRK2) have been shown to associate with Parkinson's disease (PD). Several mutations have been found in PD populations from different parts of the world. We investigated the occurrence of three mutations (R1441G/C/H, G2019S, and I2020T) in our Swedish case-control material and identified four carriers of the G2019S mutation in 284 PD cases and 1 95-year-old carrier in 305 controls. The other two variants were absent in our material. We conclude that the LRRK2 G2019S mutation constitutes a significant factor for PD in the Swedish population and that it is not completely penetrant.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?